Similar articles for PMID: 1730972

Year	Number of Results
1947	1
1976	1
1989	2
1990	2
1991	1
1992	1
1993	4
1994	6
1995	6
1996	3
1997	10
1998	9
1999	2
2000	3
2001	4
2002	5
2003	3
2005	2
2006	1
2007	1
2024	0

1

Cyclic oral phosphate and etidronate increase femoral and lumbar bone mineral density and reduce lumbar spine fracture rate over three years.

Silberstein EB, Schnur W. Silberstein EB, et al. J Nucl Med. 1992 Jan;33(1):1-5. J Nucl Med. 1992. PMID: 1730972 Free article. Clinical Trial.

2

Effects of cyclical etidronate with alfacalcidol on lumbar bone mineral density, bone resorption, and back pain in postmenopausal women with osteoporosis.

Iwamoto J, Takeda T, Ichimura S, Matsu K, Uzawa M. Iwamoto J, et al. J Orthop Sci. 2003;8(4):532-7. doi: 10.1007/s00776-003-0655-5. J Orthop Sci. 2003. PMID: 12898306 Clinical Trial.

3

Intermittent cyclical etidronate treatment of postmenopausal osteoporosis.

Watts NB, Harris ST, Genant HK, Wasnich RD, Miller PD, Jackson RD, Licata AA, Ross P, Woodson GC 3rd, Yanover MJ, et al. Watts NB, et al. N Engl J Med. 1990 Jul 12;323(2):73-9. doi: 10.1056/NEJM199007123230201. N Engl J Med. 1990. PMID: 2113611 Free article. Clinical Trial.

4

The use of etidronate and calcium versus calcium alone in the treatment of postmenopausal osteopenia: results of three years of treatment.

Montessori ML, Scheele WH, Netelenbos JC, Kerkhoff JF, Bakker K. Montessori ML, et al. Osteoporos Int. 1997;7(1):52-8. doi: 10.1007/BF01623461. Osteoporos Int. 1997. PMID: 9102064 Clinical Trial.

5

Cyclical etidronate plus ergocalciferol prevents glucocorticoid-induced bone loss in postmenopausal women.

Diamond T, McGuigan L, Barbagallo S, Bryant C. Diamond T, et al. Am J Med. 1995 May;98(5):459-63. doi: 10.1016/S0002-9343(99)80345-3. Am J Med. 1995. PMID: 7733124 Clinical Trial.

6

Effects of cyclical etidronate combined with calcitriol versus cyclical etidronate alone on spine and femoral neck bone mineral density in postmenopausal osteoporotic women.

Masud T, Mulcahy B, Thompson AV, Donnelly S, Keen RW, Doyle DV, Spector TD. Masud T, et al. Ann Rheum Dis. 1998 Jun;57(6):346-9. doi: 10.1136/ard.57.6.346. Ann Rheum Dis. 1998. PMID: 9771208 Free PMC article. Clinical Trial.

7

A comparison of the effect of risedronate and etidronate on lumbar bone mineral density in Japanese patients with osteoporosis: a randomized controlled trial.

Fukunaga M, Kushida K, Kishimoto H, Shiraki M, Taketani Y, Minaguchi H, Inoue T, Morita R, Morii H, Yamamoto K, Ohashi Y, Orimo H; Risedronate Phase III Research Group. Fukunaga M, et al. Osteoporos Int. 2002 Dec;13(12):971-9. doi: 10.1007/s001980200135. Osteoporos Int. 2002. PMID: 12459940 Clinical Trial.

8

Effects of combined treatment with etidronate, nandrolone-decanoate and calcium on bone mineral density in postmenopausal women.

Bolanca S, Korsić M, Dekanić D, Cvijetić S. Bolanca S, et al. Acta Med Croatica. 1998;52(3):159-63. Acta Med Croatica. 1998. PMID: 9818438

9

Management of male osteoporosis.

Cortet B, Vasseur J, Grardel B, Catanzariti L, Marchandise X, Delcambre B. Cortet B, et al. Joint Bone Spine. 2001 May;68(3):252-6. doi: 10.1016/s1297-319x(01)00272-x. Joint Bone Spine. 2001. PMID: 11394626 Clinical Trial.

10

Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis.

Adachi JD, Bensen WG, Brown J, Hanley D, Hodsman A, Josse R, Kendler DL, Lentle B, Olszynski W, Ste-Marie LG, Tenenhouse A, Chines AA. Adachi JD, et al. N Engl J Med. 1997 Aug 7;337(6):382-7. doi: 10.1056/NEJM199708073370603. N Engl J Med. 1997. PMID: 9241127 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

67 results

Results by year